Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial

NCT02098395 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT02098395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02098395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2014
Completion date
April 30, 2015
Enrollment
835 (actual)
Sites
120

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 1